Matts Kågedal

A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066 — Estimating occupancy in the absence of a reference region

Matts Kågedal, Zsolt Cselényi, Svante Nyberg et al. · NeuroImage · 2013 · 51 citations

Positron Emission Tomography, Healthy Volunteers, Reference Region +5

Time-to-Event Analysis of Polatuzumab Vedotin-Induced Peripheral Neuropathy to Assist in the Comparison of Clinical Dosing Regimens

Dan Lü, WR Gillespie, Sandhya Girish et al. · CPT Pharmacometrics & Systems Pharmacology · 2017 · 40 citations · Full text

Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR

Svante Nyberg, Aurelija Jučaitė, Akihiro Takano et al. · The International Journal of Neuropsychopharmacology · 2013 · 36 citations · Full text

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +20

Development of a Subcutaneous Fixed‐Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose‐Finding Study

Whitney P. Kirschbrown, Chris Wynne, Matts Kågedal et al. · The Journal of Clinical Pharmacology · 2018 · 36 citations · Full text

Modelling a Spontaneously Reported Side Effect by Use of a Markov Mixed-Effects Model

Per‐Henrik Zingmark, Matts Kågedal, Mats O. Karlsson · Journal of Pharmacokinetics and Pharmacodynamics · 2005 · 34 citations

Psychiatry, Markov Mixed-effects Model, Adverse Event +7